DBP B — Double Bond Pharmaceutical International AB (publ) Cashflow Statement
0.000.00%
- SEK46.93m
- SEK45.45m
- SEK1.37m
Annual cashflow statement for Double Bond Pharmaceutical International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.13 | -17.7 | -9.26 | -15.2 | -17.3 |
Depreciation | |||||
Non-Cash Items | -0.325 | -0.513 | -10 | 0 | 8.53 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.29 | 0.098 | -0.953 | 1.61 | 5.74 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -11.6 | -18 | -20 | -13.4 | -3.08 |
Capital Expenditures | -0.136 | -0.502 | -0.326 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 1.67 | 0 | -6.21 |
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Cash from Investing Activities | -0.136 | -0.502 | 1.34 | 0 | -6.21 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 13 | 28.6 | 15.9 | 3.34 | 10.6 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.23 | 10.1 | -2.83 | -10 | 1.33 |